Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Medical Software Company IQ-AI Raises GBP250,000 Via Share Placing

Wed, 26th Jun 2019 14:08

(Alliance News) - IQ-AI Ltd on Wednesday said it has raised GBP250,000 through a share placing.

The medical software company said it issued 7.1 million shares at a price of 3.5 pence each.

IQ-AI shares were trading 12% lower on Wednesday afternoon at 3.82p each, giving it a market capitalisation of GBP4.6 million.

Peterhouse Capital Ltd was acting as the company's financial adviser and broker.

The company said it will use the funds to accelerate the development of its current imaging biometrics artificial intelligence projects, including Stone Checker, in response to rapidly growing interest in these technologies by medical practitioners.

Following completion of the placing, IQ-AI's issued share capital will consist of 127.5 million shares, it said.

Related Shares

More News
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to...

9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Adminis...

2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD...

10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population coho...

19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which i...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.